[Intra-systemic inhibitors of the hematopoietic system].
Physiological, experimental and theoretical aspects concerning haemopoietic inhibitors are reviewed. In the paper there are also discussed future research directions of this branch of haematology.
Ratajczak
M Z
MZ
Szczylik
C
C
D000527:Alprostadil / Q000502:physiology; D000818:Animals; D015232:Dinoprostone / Q000502:physiology; D006131:Growth Inhibitors / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D016898:Interferon-alpha / Q000502:physiology; D016899:Interferon-beta / Q000502:physiology; D007371:Interferon-gamma / Q000502:physiology; D007781:Lactoferrin / Q000502:physiology; D008222:Lymphokines / Q000502:physiology*; D051379:Mice; D008954:Models, Biological; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D006131:Growth Inhibitors; D016898:Interferon-alpha; D008222:Lymphokines; D014409:Tumor Necrosis Factor-alpha; C022173:stem cell inhibitory factor; D016899:Interferon-beta; D007371:Interferon-gamma; D007781:Lactoferrin; D000527:Alprostadil; D015232:Dinoprostone
Wewnatrzustrojowe inhibitory układu krwiotwórczego.